Clinical Trial Update: Nebulized or Inhaled Albuterol for Lymphangioleiomyomatosis [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial is evaluating nebulized or inhaled albuterol as a treatment for lymphangioleiomyomatosis in Phase 1 and Phase 2. The study is currently recr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lymphangioleiomyomatosis

Drugs mentioned

• Albuterol (nebulized/inhaled) (albuterol)

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Lymphangioleiomyomatosis | Phase 1, Phase 2 | Status: RECRUITING